Arbutus Biopharma Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arbutus Biopharma Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Arbutus Biopharma Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.24M, a 22% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.24M -$348K -22% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.33M -$338K -20.3% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.42M -$328K -18.8% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.5M -$319K -17.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.59M -$337K -17.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.67M -$342K -17% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.74M -$348K -16.6% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $1.82M -$353K -16.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.92M -$303K -13.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.01M -$308K -13.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.09M -$313K -13% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.17M -$317K -12.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $2.23M -$350K -13.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.32M -$342K -12.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $2.41M -$333K -12.2% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $2.49M -$326K -11.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.58M -$326K -11.2% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $2.66M -$424K -13.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.74M +$2.74M Dec 31, 2019 10-K 2021-03-04
Q3 2019 $2.82M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $2.9M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $3.08M Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.